Across the Atlantic, Verizon presents itself as a company on firmer ground. Leadership has changed, subscriber growth has resumed, full-year earnings guidance has been raised, and free cash flow is heading for its highest level since the pandemic even as capital expenditure falls. That last detail matters to anyone who depends on coverage. A carrier that spends less on building networks is making a rational choice for shareholders, and the places that feel it first are those where each new mast serves few customers. Verizon also sells connectivity to healthcare providers for remote monitoring, so its clinical customers sit on the same network economics as everyone else.

Satellite operators now propose to put cellular base station capability into low-Earth orbit and connect ordinary handsets directly. They hold their own spectrum, and launch timelines are measured in months and years rather than decades. Engineering has limits. Capacity in orbit is shared across enormous footprints, and signals struggle to penetrate the buildings of dense cities. The competitive threat to established carriers is therefore real but uneven, strongest where people are few and weakest where they are many.

Britain has no Verizon, yet it carries the same dependency. The NHS has committed to moving care from hospitals into communities, with virtual wards, home monitoring and the NHS App as the expected front door. Each of these assumes a working connection at the patient's bedside and on the clinician's round. The Shared Rural Network, funded jointly by government and operators, aims to extend 4G across 95 per cent of the UK landmass, but partial notspots persist in precisely the upland and coastal areas where services are hardest to staff. Meanwhile the digital switchover of landlines, due to complete by early 2027, is moving telecare alarms onto networks that can fail with a power cut. Ofcom has begun opening the way for direct-to-device satellite services, which may ease some of this, though not on a clinical timetable.

The central problem is one of governance. Connectivity is bought by NHS organisations as a utility, through commercial contracts, with no say over where operators choose to invest. Yet a dropped signal now has clinical consequences: a missed deterioration, a delayed alert, an unreliable record. Satellite competition may improve coverage for rural patients, but it will arrive when commercial logic allows and at a price set by it. Shared capacity will also favour small packets of data such as readings, alarms and location over the video consultations that digital strategies tend to showcase.

For NHS leaders, the practical task is dull and urgent. Coverage should be mapped against caseloads before remote monitoring is expanded into an area, and devices should store readings and forward them when a connection returns. Procurement specifications should require a tested fallback, and board risk registers should list network failure alongside workforce gaps and estate condition. Policymakers have a parallel job. Spectrum decisions, universal service obligations and rural coverage targets are currently shaped with consumers and the economy in mind, and the Department of Health and Social Care has seldom been a visible voice in those discussions. Health-tech suppliers can gain from designing for degraded networks as a baseline condition, which is a stronger selling point than a polished interface that works only in a city centre.

Patients deserve candour as well. Remote care is sold as convenience and safer than a hospital stay for many conditions, and that holds where the connection does. Where it does not, the home becomes an unmonitored ward.

Verizon's recovery shows how a network operator earns its money and where it will choose to stop spending. The NHS should plan on that basis. A flat line on a dashboard should never be ambiguous, and nobody should depend on the commercial priorities of a carrier to find out which it is.

‍